.Cognition Therapeutics' stage 2 SHINE trial has actually taken some of the radiance off the Alzheim...
.Bristol Myers Squibb has had a whiplash change of mind on its own BCMA bispecific T-cell engager, s...
.Charles Baum, M.D., Ph.D., who managed Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squibb...
.After connecting to much more than 200 business to companion a Tourette syndrome therapy that revea...
.Novartis has possessed some rotten luck along with bispecific antibodies over the last, but determi...
.Pinetree Rehabs will definitely assist AstraZeneca plant some trees in its pipeline with a brand ne...
.GRO Biosciences has actually finished the week with an extra $60.3 thousand in the financial instit...
.Invite to this week's Chutes & Ladders, our roundup of notable management hirings, firings and r...